| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Wave Life Sciences Ltd. (WVE) has 12 insiders with recent SEC Form 4 filings, including 5 buys and 6 sells. WVE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 26.98M | $162.39M | - | |
| Dir | 5.73M | $34.49M | - | |
| Other | 408.2K | $2.46M | - | |
| Dir | 283.2K | $1.70M | - | |
| CEO | 275.5K | $1.66M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 22, 2017 | Vargeese Chandra | See Remarks | Sale+OE | 1,500 | $35.00 | $52,500.00 | -100% | |
| Nov 14, 2017 | Ra Capital Management, LLC52 | Director, 10% Owner | Buy | 423,398 | $23.34 | $9,881,549.66 | +2.9% | |
| Sep 18, 2017 | Tanaka Masaharu | Director, 10% Owner | Sell | 20,747 | $24.21 | $502,301.48 | -0.4% | |
| Jul 12, 2017 | Panzara Michael A. | Franchise Lead, Neurology | Sell | 7,414 | $16.67 | $123,619.55 | -32.6% | |
| Mar 29, 2017 | Tanaka Masaharu | Director, 10% Owner | Sell | 433,825 | $24.91 | $10,806,580.75 | -13.4% | |
| Jun 15, 2016 | Verdine Gregory L.63 | Director | Sell | 52,000 | $16.70 | $868,400.00 | -25.7% | |
| Nov 16, 2015 | Tanaka Masaharu | Director, 10% Owner | Buy | 76,250 | $16.00 | $1,220,000.00 | +2.4% | |
| Nov 16, 2015 | Takanashi Ken | Director, 10% Owner | Buy | 125,000 | $16.00 | $2,000,000.00 | +6.7% | |
| Nov 16, 2015 | Ra Capital Management, LLC52 | Director, 10% Owner | Buy | 1,875,000 | $16.00 | $30,000,000.00 | +36.0% |